Mario Salmona
#149,825
Most Influential Person Now
Researcher
Mario Salmona's AcademicInfluence.com Rankings
Mario Salmonacomputer-science Degrees
Computer Science
#7794
World Rank
#8201
Historical Rank
Computational Linguistics
#1633
World Rank
#1650
Historical Rank
Machine Learning
#3008
World Rank
#3045
Historical Rank
Artificial Intelligence
#3304
World Rank
#3352
Historical Rank
Download Badge
Computer Science
Mario Salmona's Degrees
- PhD Computer Science Stanford University
- Masters Computer Science University of California, Berkeley
Similar Degrees You Can Earn
Why Is Mario Salmona Influential?
(Suggest an Edit or Addition)Mario Salmona's Published Works
Number of citations in a given year to any of this author's works
Total number of citations to an author for the works they published in a given year. This highlights publication of the most important work(s) by the author
Published Works
- Neurotoxicity of a prion protein fragment (1993) (930)
- Identification by redox proteomics of glutathionylated proteins in oxidatively stressed human T lymphocytes (2002) (541)
- Synthetic amyloid-β oligomers impair long-term memory independently of cellular prion protein (2010) (430)
- Multimer Formation and Ligand Recognition by the Long Pentraxin PTX3 (1997) (395)
- Regulation of the macrophage content of neoplasms by chemoattractants. (1983) (365)
- A Recessive Mutation in the APP Gene with Dominant-Negative Effect on Amyloidogenesis (2009) (365)
- Apoptosis mediated neurotoxicity induced by chronic application of beta amyloid fragment 25-35. (1993) (365)
- CtBP/BARS induces fission of Golgi membranes by acylating lysophosphatidic acid (1999) (344)
- Glutathionylation of human thioredoxin: A possible crosstalk between the glutathione and thioredoxin systems (2002) (336)
- Inhibition of Monocyte Chemotactic Protein-1 Synthesis by Statins (2000) (322)
- The SIRT1 activator resveratrol protects SK‐N‐BE cells from oxidative stress and against toxicity caused by α‐synuclein or amyloid‐β (1‐42) peptide (2009) (238)
- In Vivo Anti-Inflammatory Effect of Statins Is Mediated by Nonsterol Mevalonate Products (2001) (236)
- Cloning of mouse ptx3, a new member of the pentraxin gene family expressed at extrahepatic sites. (1996) (233)
- Anti‐amyloidogenic activity of tetracyclines: studies in vitro (2001) (215)
- Molecular characteristics of a protease-resistant, amyloidogenic and neurotoxic peptide homologous to residues 106-126 of the prion protein. (1993) (203)
- Evaluation of Quinacrine Treatment for Prion Diseases (2003) (194)
- Curcumin-decorated nanoliposomes with very high affinity for amyloid-β1-42 peptide. (2011) (189)
- Tetracyclines affect prion infectivity (2002) (188)
- Conformational polymorphism of the amyloidogenic and neurotoxic peptide homologous to residues 106-126 of the prion protein. (1994) (185)
- Protein Nitration in a Mouse Model of Familial Amyotrophic Lateral Sclerosis (2005) (184)
- Lipid-based nanoparticles with high binding affinity for amyloid-beta1-42 peptide. (2010) (175)
- Effectiveness of anthracycline against experimental prion disease in Syrian hamsters. (1997) (172)
- Tetracycline affects abnormal properties of synthetic PrP peptides and PrP(Sc) in vitro. (2000) (159)
- Functionalization of liposomes with ApoE-derived peptides at different density affects cellular uptake and drug transport across a blood-brain barrier model. (2011) (156)
- Doxycycline in Creutzfeldt-Jakob disease: a phase 2, randomised, double-blind, placebo-controlled trial (2014) (141)
- JNK regulates APP cleavage and degradation in a model of Alzheimer's disease (2009) (140)
- Microglial cells respond to amyloidogenic PrP peptide by the production of inflammatory cytokines. (1999) (131)
- Squalestatin Cures Prion-infected Neurons and Protects Against Prion Neurotoxicity* (2004) (129)
- Induction of apoptosis in human leukemic cells by the ether lipid 1‐octadecyl‐2‐methyl‐RAC‐glycero‐3‐ phosphocholine. A possible basis for its selective action (1993) (125)
- Colloidal stability of polymeric nanoparticles in biological fluids (2012) (121)
- A 7-kDa Prion Protein (PrP) Fragment, an Integral Component of the PrP Region Required for Infectivity, Is the Major Amyloid Protein in Gerstmann-Sträussler-Scheinker Disease A117V* (2001) (121)
- Oleuropein Aglycone Protects Transgenic C. elegans Strains Expressing Aβ42 by Reducing Plaque Load and Motor Deficit (2013) (116)
- A Caenorhabditis elegans-based assay recognizes immunoglobulin light chains causing heart amyloidosis. (2014) (115)
- Multifunctional Liposomes Reduce Brain β-Amyloid Burden and Ameliorate Memory Impairment in Alzheimer's Disease Mouse Models (2014) (115)
- Safety and Toxicology of Magnolol and Honokiol (2018) (112)
- Purification, cDNA Cloning, and Tissue Distribution of Bovine Liver Aldehyde Oxidase (*) (1995) (111)
- Activation of microglial cells by PrP and β-amyloid fragments raises intracellular calcium through L-type voltage sensitive calcium channels (1999) (111)
- Influence of Size and Shape on the Anatomical Distribution of Endotoxin-Free Gold Nanoparticles. (2017) (110)
- Characterization of Detergent-Insoluble Proteins in ALS Indicates a Causal Link between Nitrative Stress and Aggregation in Pathogenesis (2009) (110)
- Tetracycline and its analogues protect Caenorhabditis elegans from β amyloid-induced toxicity by targeting oligomers (2010) (107)
- Neuroprotective effects of the Sigma-1 receptor (S1R) agonist PRE-084, in a mouse model of motor neuron disease not linked to SOD1 mutation (2014) (106)
- Phosphatidic Acid and Lysophosphatidic Acid Induce Haptotactic Migration of Human Monocytes (*) (1995) (105)
- A Neurotoxic Prion Protein Fragment Induces Rat Astroglial Proliferation and Hypertrophy (1994) (104)
- Insoluble Mutant SOD1 Is Partly Oligoubiquitinated in Amyotrophic Lateral Sclerosis Mice* (2006) (104)
- Toll-like receptor 4-dependent glial cell activation mediates the impairment in memory establishment induced by β-amyloid oligomers in an acute mouse model of Alzheimer’s disease (2017) (103)
- Molecular determinants of the physicochemical properties of a critical prion protein region comprising residues 106-126. (1999) (102)
- Blood protein coating of gold nanoparticles as potential tool for organ targeting. (2014) (101)
- Effect of Tetracyclines on the Dynamics of Formation and Destructuration of β2-Microglobulin Amyloid Fibrils*♦ (2010) (97)
- Functionalization with ApoE-derived peptides enhances the interaction with brain capillary endothelial cells of nanoliposomes binding amyloid-beta peptide. (2011) (96)
- Membrane fluidity affects tumor‐cell motility, invasion and lung‐colonizing potential (1989) (94)
- p21WAF1-derived peptides linked to an internalization peptide inhibit human cancer cell growth. (1997) (94)
- The Efficacy of Tetracyclines in Peripheral and Intracerebral Prion Infection (2008) (94)
- Molecular Cloning and Functional Characterization of Brefeldin A-ADP-ribosylated Substrate (1999) (93)
- A soluble form of prion protein in human cerebrospinal fluid: implications for prion-related encephalopathies. (1992) (89)
- Inhibition of cancer cell growth and c-Myc transcriptional activity by a c-Myc helix 1-type peptide fused to an internalization sequence. (1998) (88)
- Huprine-tacrine heterodimers as anti-amyloidogenic compounds of potential interest against Alzheimer's and prion diseases. (2012) (85)
- c-Jun N-terminal kinase has a key role in Alzheimer disease synaptic dysfunction in vivo (2014) (83)
- Enhanced xanthine oxidase activity in mice treated with interferon and interferon inducers. (1984) (83)
- Prion protein fragment 106–126 induces apoptotic cell death and impairment of L‐type voltage‐sensitive calcium channel activity in the GH3 cell line (1998) (82)
- Apoptotic Cell Death and Impairment of L-Type Voltage-Sensitive Calcium Channel Activity in Rat Cerebellar Granule Cells Treated with the Prion Protein Fragment 106–126 (2000) (81)
- Clusterin Binds to Aβ1–42 Oligomers with High Affinity and Interferes with Peptide Aggregation by Inhibiting Primary and Secondary Nucleation* (2016) (81)
- Role of reactive oxygen intermediates in the interferon-mediated depression of hepatic drug metabolism and protective effect of N-acetylcysteine in mice. (1985) (79)
- Ginkgolide B inhibits the neurotoxicity of prions or amyloid-β1-42 (2004) (79)
- Intracellular calcium rise through L-type calcium channels, as molecular mechanism for prion protein fragment 106-126-induced astroglial proliferation. (1996) (78)
- P3-357 Structural properties of gerstmann-Sträussler-Scheinker disease amyloid protein (2003) (77)
- A new face for old antibiotics: tetracyclines in treatment of amyloidoses. (2013) (76)
- Amino terminal region of acute phase, but not constitutive, serum amyloid A (apoSAA) specifically binds and transports cholesterol into aortic smooth muscle and HepG2 cells. (1996) (76)
- Carrageenan-induced acute inflammation in the mouse air pouch synovial model. Role of tumour necrosis factor (1997) (75)
- Proteomic analysis of spinal cord of presymptomatic amyotrophic lateral sclerosis G93A SOD1 mouse. (2007) (73)
- Longitudinal Amyloid Imaging in Mouse Brain with 11C-PIB: Comparison of APP23, Tg2576, and APPswe-PS1dE9 Mouse Models of Alzheimer Disease (2013) (71)
- The binding affinity of anti-Aβ1-42 MAb-decorated nanoliposomes to Aβ1-42 peptides in vitro and to amyloid deposits in post-mortem tissue. (2011) (69)
- Decreased half life of cyclophosphamide in patients under continual treatment. (1979) (68)
- Cloning of the cDNAs Coding for Two Novel Molybdo-flavoproteins Showing High Similarity with Aldehyde Oxidase and Xanthine Oxidoreductase* (2000) (68)
- Apoptosis-mediated neurotoxicity induced by β-amyloid and PRP fragments (1996) (67)
- The Stimulation of Inducible Nitric-oxide Synthase by the Prion Protein Fragment 106–126 in Human Microglia Is Tumor Necrosis Factor-α-dependent and Involves p38 Mitogen-activated Protein Kinase* (2001) (67)
- A specific gas chromatographic method for the determination of microsomal styrene monooxygenase and styrene epoxide hydratase activities. (1976) (65)
- Blood-Brain Barrier Alterations in the Cerebral Cortex in Experimental Autoimmune Encephalomyelitis (2012) (63)
- Inhibition of Aβ Amyloid Growth and Toxicity by Silybins: The Crucial Role of Stereochemistry. (2017) (62)
- The Aldehyde Oxidase Gene Cluster in Mice and Rats (2004) (61)
- Organ Distribution and Bone Tropism of Cellulose Nanocrystals in Living Mice. (2015) (60)
- Arene oxides in styrene metabolism, a new perspective in styrene toxicity? (1978) (60)
- A portable optical-fibre-based surface plasmon resonance biosensor for the detection of therapeutic antibodies in human serum (2020) (59)
- A Neurotoxic and Gliotrophic Fragment of the Prion Protein Increases Plasma Membrane Microviscosity (1997) (59)
- [[(Arylpiperazinyl)alkyl]thio]thieno[2,3-d]pyrimidinone derivatives as high-affinity, selective 5-HT1A receptor ligands. (1997) (59)
- The Molecular Assembly of Amyloid Aβ Controls Its Neurotoxicity and Binding to Cellular Proteins (2011) (59)
- The neurotoxicity of prion protein (PrP) peptide 106–126 is independent of the expression level of PrP and is not mediated by abnormal PrP species (2005) (59)
- Aging and food restriction: Effect on lipids of cerebral cortex (1991) (59)
- Role of cell cholesterol in modulating antineoplastic ether lipid uptake, membrane effects and cytotoxicity (1990) (58)
- Applications of Surface Plasmon Resonance (SPR) for the Characterization of Nanoparticles Developed for Biomedical Purposes (2012) (57)
- Conformational plasticity of the Gerstmann-Sträussler-Scheinker disease peptide as indicated by its multiple aggregation pathways. (2008) (57)
- Hepatic and extrahepatic formation and hydration of styrene oxide in vitro in animals of different species and sex (1978) (57)
- Mono and Dually Decorated Nanoliposomes for Brain Targeting, In Vitro and In Vivo Studies (2014) (56)
- Neuropathology of the recessive A673V APP mutation: Alzheimer disease with distinctive features (2010) (56)
- Tumor‐derived chemotactic factor(S) from human ovarian carcinoma: Evidence for a role in the regulation of macrophage content of neoplastic tissues (1985) (56)
- Channels formed with a mutant prion protein PrP(82-146) homologous to a 7-kDa fragment in diseased brain of GSS patients. (2003) (54)
- Tetracycline prevents Aβ oligomer toxicity through an atypical supramolecular interaction. (2011) (54)
- Intracellular mechanisms mediating the neuronal death and astrogliosis induced by the prion protein fragment 106–126 (2000) (53)
- Chemotactic activity for mononuclear phagocytes of culture supernatants from murine and human tumor cells: Evidence for a role in the regulation of the macrophage content of neoplastic tissues (1983) (52)
- Specific Recognition of Biologically Active Amyloid-β Oligomers by a New Surface Plasmon Resonance-based Immunoassay and an in Vivo Assay in Caenorhabditis elegans* (2012) (51)
- New method based on capillary electrophoresis with laser-induced fluorescence detection (CE-LIF) to monitor interaction between nanoparticles and the amyloid-β peptide. (2010) (50)
- The induction of apoptosis is a common feature of the cytotoxic action of ether‐linked glycerophospholipids in human leukemic cells (1994) (50)
- Activation effects of a prion protein fragment [PrP-(106-126)] on human leucocytes. (1996) (50)
- Tetracyclines and prion infectivity. (2009) (50)
- Regulation and Biochemistry of Mouse Molybdo-flavoenzymes (2004) (49)
- Purification of the Aldehyde Oxidase Homolog 1 (AOH1) Protein and Cloning of the AOH1 and Aldehyde Oxidase Homolog 2 (AOH2) Genes (2001) (49)
- Porphyrogenic effect of chronic treatment with 2,3,7,8-tetrachlorodibenzo-p-dioxin in female rats. Dose--effect relationship following urinary excretion of porphyrins. (1981) (48)
- Amyloid in alzheimer's disease and prion-related encephalopathies: Studies with synthetic peptides (1996) (47)
- The Peculiar Role of the A2V Mutation in Amyloid-β (Aβ) 1–42 Molecular Assembly* (2014) (46)
- Studies on peptide fragments of prion proteins. (2001) (46)
- Microsomal styrene mono-oxygenase and styrene epoxide hydrase activities in rats. (1976) (45)
- Doxycycline counteracts neuroinflammation restoring memory in Alzheimer's disease mouse models (2018) (44)
- New mutations in MAPT gene causing frontotemporal lobar degeneration: biochemical and structural characterization (2012) (44)
- Localization and age‐dependent expression of the inward rectifier K+ channel subunit Kir 5.1 in a mammalian reproductive system (1999) (44)
- The hunt for brain Aβ oligomers by peripherally circulating multi-functional nanoparticles: Potential therapeutic approach for Alzheimer disease. (2016) (43)
- β25–35 Alters Calcium Homeostasis and Induces Neurotoxicity in Cerebellar Granule Cells (1996) (43)
- Targeting dopamine D3 and serotonin 5-HT1A and 5-HT2A receptors for developing effective antipsychotics: synthesis, biological characterization, and behavioral studies. (2014) (43)
- Functionalization with TAT-peptide enhances blood-brain barrier crossing in vitro of nanoliposomes carrying a curcumin-derivative to bind amyloid-β peptide (2013) (43)
- Redox regulation of cyclophilin A by glutathionylation (2006) (43)
- Plasma and Brain Concentrations of Doxycycline after Single and Repeated Doses in Wild-Type and APP23 Mice (2018) (39)
- Synthetic Miniprion PrP106* (2002) (39)
- Pyrroloquinoxaline hydrazones as fluorescent probes for amyloid fibrils. (2011) (39)
- Different mutations at V363 MAPT codon are associated with atypical clinical phenotypes and show unusual structural and functional features (2014) (38)
- Use of surface plasmon resonance to study the elongation kinetics and the binding properties of the highly amyloidogenic Aβ(1-42) peptide, synthesized by depsi-peptide technique. (2011) (38)
- Role of Nrf2, HO-1 and GSH in Neuroblastoma Cell Resistance to Bortezomib (2016) (38)
- beta PP and Tau interaction. A possible link between amyloid and neurofibrillary tangles in Alzheimer's disease. (1996) (37)
- cis-Glyco-fused benzopyran compounds as new amyloid-β peptide ligands. (2011) (37)
- The role of platelet activating factor in prion and amyloid-beta neurotoxicity. (2004) (37)
- NMR-driven identification of anti-amyloidogenic compounds in green and roasted coffee extracts. (2018) (37)
- A modified protocol to prepare seed-free starting solutions of amyloid-β (Aβ)₁₋₄₀ and Aβ₁₋₄₂ from the corresponding depsipeptides. (2011) (37)
- Curcumin derivatives as new ligands of Aβ peptides. (2011) (37)
- Wax Esters of n -3 Polyunsaturated Fatty Acids: A New Stable Formulation as a Potential Food Supplement. 1 — Digestion and Absorption in Rats (2002) (36)
- Apoptosis-mediated neurotoxicity induced by beta-amyloid and PrP fragments. (1996) (36)
- Characterization of type II intracellular IL‐1 receptor antagonist (IL‐1ra3): a depot IL‐1ra (1999) (36)
- Natural compounds against neurodegenerative diseases: molecular characterization of the interaction of catechins from green tea with Aβ1-42, PrP106-126, and ataxin-3 oligomers. (2014) (36)
- c-Jun N-terminal kinase binding domain–dependent phosphorylation of mitogen-activated protein kinase kinase 4 and mitogen-activated protein kinase kinase 7 and balancing cross-talk between c-Jun N-terminal kinase and extracellular signal-regulated kinase pathways in cortical neurons (2009) (36)
- Cardiac Light Chain Amyloidosis: The Role of Metal Ions in Oxidative Stress and Mitochondrial Damage. (2017) (36)
- Placental transfer of valproic acid after liposome encapsulation during in vitro human placenta perfusion. (1996) (36)
- Spectroscopic and binding studies on the interaction of inorganic anions with lactoperoxidase. (1997) (35)
- A Surface Plasmon Resonance-based assay to measure serum concentrations of therapeutic antibodies and anti-drug antibodies (2019) (35)
- Mutant Prion Protein Expression Is Associated with an Alteration of the Rab GDP Dissociation Inhibitor α (GDI)/Rab11 Pathway* (2009) (35)
- Gerstmann-Sträussler-Scheinker Disease Amyloid Protein Polymerizes According to the “Dock-and-Lock” Model* (2006) (35)
- Aggregation/fibrillogenesis of recombinant human prion protein and Gerstmann-Sträussler-Scheinker disease peptides in the presence of metal ions. (2006) (35)
- Role of surfactant in chronic obstructive pulmonary disease: therapeutic implications. (1992) (35)
- Amidation of β‐Amyloid Peptide Strongly Reduced the Amyloidogenic Activity Without Alteration of the Neurotoxicity (1997) (35)
- Conformational polymorphism of the PrP106-126 peptide in different environments: a molecular dynamics study. (2006) (34)
- Neurotoxic and Gliotrophic Activity of a Synthetic Peptide Homologous to Gerstmann–Sträussler–Scheinker Disease Amyloid Protein (2007) (34)
- A theoretical three-dimensional model for lactoperoxidase and eosinophil peroxidase, built on the scaffold of the myeloperoxidase X-ray structure (1996) (33)
- Expression of Mutant or Cytosolic PrP in Transgenic Mice and Cells Is Not Associated with Endoplasmic Reticulum Stress or Proteasome Dysfunction (2011) (33)
- In vivo fate of avidin-nucleic acid nanoassemblies as multifunctional diagnostic tools. (2014) (33)
- Overcoming synthetic Aβ peptide aging: a new approach to an age-old problem (2009) (32)
- Cytoplasmic domain of human myelin protein zero likely folded as beta-structure in compact myelin. (2007) (32)
- Reye's and Reye-like syndromes, drug-related diseases? (causative agents, etiology, pathogenesis, and therapeutic approaches). (1995) (31)
- Synthesis and evaluation of a (18)F-curcumin derivate for β-amyloid plaque imaging. (2014) (31)
- Clusterin (SGP‐2) Induction in Rat Astroglial Cells Exposed to Prion Protein Fragment 106–126 (1996) (31)
- Intercalation with DNA is a prerequisite for daunomycin, adriamycin and its congeners in inhibiting DNAase I. (1978) (30)
- Diazepam increases membrane fluidity of rat hippocampus synaptosomes (1984) (30)
- Amyloidβ Peptides in interaction with raft-mime model membranes: a neutron reflectivity insight (2016) (30)
- Prion Protein Fragment 106–126 Differentially Induces Heme Oxygenase‐1 mRNA in Cultured Neurons and Astroglial Cells (1997) (30)
- IFN-beta-induced reduction of superoxide anion generation by macrophages. (1982) (30)
- Molybdenum(VI) salts convert the xanthine oxidoreductase apoprotein into the active enzyme in mouse L929 fibroblastic cells. (1994) (29)
- Dexamethasone Conjugation to Biodegradable Avidin-Nucleic-Acid-Nano-Assemblies Promotes Selective Liver Targeting and Improves Therapeutic Efficacy in an Autoimmune Hepatitis Murine Model. (2019) (29)
- A novel pharmacological approach for paraquat poisoning in rat and A549 cell line using ambroxol, a lung surfactant synthesis inducer. (1992) (29)
- Longitudinal Tracking of Human Fetal Cells Labeled with Super Paramagnetic Iron Oxide Nanoparticles in the Brain of Mice with Motor Neuron Disease (2012) (29)
- QSAR model for blood-brain barrier permeation. (2017) (29)
- Good gene, bad gene: New APP variant may be both (2012) (29)
- Determination of solution conformations of PrP106-126, a neurotoxic fragment of prion protein, by 1H NMR and restrained molecular dynamics. (1999) (29)
- Extracellular glutamate levels in the hypothalamus and hippocampus of rats after acute or chronic oral intake of monosodium glutamate (1995) (28)
- Beta‐amyloid 1‐42 monomers, but not oligomers, produce PHF‐like conformation of Tau protein (2016) (28)
- Isolation and structure determination of enzymatically formed styrene oxide glutathione conjugates. (1979) (28)
- Biocompatible fluorescent nanoparticles for in vivo stem cell tracking (2013) (28)
- In vitro hydrolysis of oxazepam succinate half-ester by a stereospecific soluble esterase from different animal species. (1974) (28)
- Selenoprotein N is an endoplasmic reticulum calcium sensor that links luminal calcium levels to a redox activity (2020) (28)
- Liver DNA alkylation after a single carcinogenic dose of dimethylnitrosamine to newborn and adult CFW Swiss mice. (1988) (28)
- Expression of A2V-mutated Aβ in Caenorhabditis elegans results in oligomer formation and toxicity (2014) (28)
- Monte Carlo method for predicting of cardiac toxicity: hERG blocker compounds. (2016) (28)
- Soluble Aβ oligomer-induced synaptopathy: c-Jun N-terminal kinase's role. (2013) (27)
- HIV-1 matrix protein p17 misfolding forms toxic amyloidogenic assemblies that induce neurocognitive disorders (2017) (27)
- Doxycycline hinders phenylalanine fibril assemblies revealing a potential novel therapeutic approach in phenylketonuria (2015) (27)
- Intact human lymphocyte membranes respond to muscarinic receptor stimulation by oxotremorine with marked changes in microviscosity and an increase in cyclic GMP (1985) (27)
- Interferon decreases production of hydrogen peroxide by macrophages: correlation with reduction of suppressive capacity and of anti-microbial activity. (1983) (27)
- N-Acetyl-β-d-glucosaminidase (NAG) and NAG isoenzymes in children with upper and lower urinary tract infections (1983) (27)
- The rate of N-demethylation of N,N-dimethylanilines and N-methylanilines by rat-liver microsomes is related to their first ionization potential, their lipophilicity and to a steric bulk factor. (1986) (27)
- An in vitro screening assay based on synthetic prion protein peptides for identification of fibril-interfering compounds. (2004) (26)
- β‐Amyloid 1‐42 induces physiological transcriptional regulation of BACE1 (2012) (26)
- Structure-activity relationships and molecular modeling studies of novel arylpiperazinylalkyl 2-benzoxazolones and 2-benzothiazolones as 5-HT(7) and 5-HT(1A) receptor ligands. (2014) (26)
- Glimepiride Reduces the Expression of PrPC, Prevents PrPSc Formation and Protects against Prion Mediated Neurotoxicity (2009) (26)
- Methodological and clinical aspects of urinary N-acetyl-glucosaminidase in pediatric subjects. (1981) (26)
- Monomeric Aβ1–42 and RAGE: key players in neuronal differentiation (2014) (25)
- Copper(II) ions affect the gating dynamics of the 20S proteasome: a molecular and in cell study (2016) (25)
- Flavonoids and Their Glycosides as Anti-amyloidogenic Compounds: Aβ1-42 Interaction Studies to Gain New Insights into Their Potential for Alzheimer's Disease Prevention and Therapy. (2017) (25)
- In vivo PET imaging of beta-amyloid deposition in mouse models of Alzheimer's disease with a high specific activity PET imaging agent [18F]flutemetamol (2014) (25)
- In vitro Evaluation of the Anti-prionic Activity of Newly Synthesized Congo Red Derivatives (2003) (25)
- C. elegans Expressing Human β2-Microglobulin: A Novel Model for Studying the Relationship between the Molecular Assembly and the Toxic Phenotype (2012) (24)
- Benefit of doxycycline treatment on articular disability caused by dialysis related amyloidosis (2013) (24)
- Kinetics of monosodium glutamate in relation to its neurotoxicity (1977) (24)
- Humanin Specifically Interacts with Amyloid-β Oligomers and Counteracts Their in vivo Toxicity. (2017) (24)
- Multifunctional LUV liposomes decorated for BBB and amyloid targeting. A. In vitro proof‐of‐concept (2017) (24)
- Acetylcholinesterase triggers the aggregation of PrP 106-126. (2006) (24)
- Increased ether lipid cytotoxicity by reducing membrane cholesterol content (1991) (23)
- Flavonoid-Derived Human Phenyl-γ-Valerolactone Metabolites Selectively Detoxify Amyloid-β Oligomers and Prevent Memory Impairment in a Mouse Model of Alzheimer's Disease. (2020) (23)
- Realistic Evaluation of Titanium Dioxide Nanoparticle Exposure in Chewing Gum. (2018) (23)
- Is there a role for nuclei in the metabolism of xenobiotica? A review. (1983) (23)
- Acetylcholinesterase as an amyloid enhancing factor in PrP82-146 aggregation process (2009) (23)
- The pneumotoxicant paraquat induces IL-8 mRNA in human mononuclear cells and pulmonary epithelial cells. (1993) (23)
- The Anti-Amyloidogenic Action of Doxycycline: A Molecular Dynamics Study on the Interaction with Aβ42 (2019) (23)
- DNA synthesis, mitotic index, drug-metabolising systems and cytogenetic analysis in regenerating rat liver. Comparison with bone marrow test after 'in vivo' treatment with cyclophosphamide. (1987) (23)
- Improved gas chromatographic method for measuring phenylethylene glycol: application to the determination of styrene monooxygenase and epoxide hydrase activities. (1980) (22)
- The influence of selenium intake on chronic adriamycin toxicity and lipid peroxidation in rats. (1983) (22)
- Prostaglandins and aminoglycoside nephrotoxicity. (1985) (22)
- Gentisic acid: an aspirin metabolite with multiple effects on human blood polymorphonuclear leukocytes. (1986) (22)
- Investigation of Functionalized Poly(N,N-dimethylacrylamide)-block-polystyrene Nanoparticles As Novel Drug Delivery System to Overcome the Blood-Brain Barrier In Vitro. (2015) (21)
- Gα13 mediates activation of the cytosolic phospholipase A2α through fine regulation of ERK phosphorylation (2006) (21)
- Therapeutic approaches to prion diseases (2000) (20)
- Characterization of arachidonic acid metabolic profiles in animal tissues by high-resolution gas chromatography-mass spectrometry. (1984) (20)
- In Vitro Aggregation Behavior of a Non-Amyloidogenic λ Light Chain Dimer Deriving from U266 Multiple Myeloma Cells (2012) (20)
- Integrated multiplatform method for in vitro quantitative assessment of cellular uptake for fluorescent polymer nanoparticles (2014) (20)
- NO-donor thiacarbocyanines as multifunctional agents for Alzheimer's disease. (2015) (20)
- Role of Plasminogen in Propagation of Scrapie (2005) (20)
- Tetracycline and its analogues as inhibitors of amyloid fibrils: searching for a geometrical pharmacophore by theoretical investigation of their conformational behavior in aqueous solution (2005) (20)
- An early developmental vertebrate model for nanomaterial safety: bridging cell-based and mammalian toxicity assessment. (2016) (20)
- Aspartame and the rat brain monoaminergic system. (1988) (20)
- Biocompatible Polymer Nanoformulation To Improve the Release and Safety of a Drug Mimic Molecule Detectable via ICP-MS. (2017) (20)
- A biodistribution study of PEGylated PCL-based nanoparticles in C57BL/6 mice bearing B16/F10 melanoma (2014) (20)
- Docosahexaenoic and eicosapentaenoic acids increase neuronal death in response to HuPrP82–146 and Aβ1–42 (2008) (20)
- Analysis of the cerebellar proteome in a transgenic mouse model of inherited prion disease reveals preclinical alteration of calcineurin activity (2006) (20)
- Tackling amyloidogenesis in Alzheimer’s disease with A2V variants of Amyloid-β (2016) (19)
- Identification of amino acid residues critical for the B cell growth-promoting activity of HIV-1 matrix protein p17 variants. (2019) (19)
- Determination of tissue levels of a neuroprotectant drug: the cell permeable JNK inhibitor peptide. (2014) (19)
- Modulation of ATPase activity by cholesterol and synthetic ether lipids in leukemic cells. (1992) (19)
- Apolipoprotein serum amyloid A down-regulates smooth-muscle cell lipid biosynthesis. (1999) (19)
- Effect of aspartame on seizures in various models of experimental epilepsy. (1988) (19)
- The anti-fibrillogenic activity of tetracyclines on PrP 106–126: a 3D-QSAR study (2008) (19)
- Prevention of chronic bronchitis exacerbations with ambroxol (mucosolvan retard). An open, long-term, multicenter study in 5,635 patients. (1989) (19)
- Interspecies and interstrain studies on the increased susceptibility to metrazol-induced convulsions in animals given aspartame. (1991) (19)
- A PP Peptide Carboxyl-Terminal to A Is Neurotoxic (1999) (18)
- Utilization of the Monte Carlo Method to Build up QSAR Models for Hemolysis and Cytotoxicity of Antimicrobial Peptides. (2017) (18)
- Docosahexaenoic and eicosapentaenoic acids increase prion formation in neuronal cells (2008) (18)
- Toxicological evaluation of urban waste incinerator emissions (1983) (18)
- Interferon inducers increase O6-alkylguanine-DNA alkyltransferase in the rat liver. (1990) (18)
- Studies on the Susceptibility to Convulsions in Animals Receiving Abuse Doses of Aspartame (1988) (18)
- Dissociation between macrophage tumoricidal capacity and suppressive activity: analysis with macrophage-defective mouse strains. (1983) (18)
- Influence of mutations associated with familial prion‐related encephalopathies on biological activity of prion protein peptides (1999) (18)
- Insights into kinetics, release, and behavioral effects of brain-targeted hybrid nanoparticles for cholesterol delivery in Huntington’s disease (2020) (18)
- Determination of argininosuccinate lyase and arginase activities with an amino acid analyzer. (1990) (18)
- Longitudinal tracking of triple labeled umbilical cord derived mesenchymal stromal cells in a mouse model of Amyotrophic Lateral Sclerosis. (2015) (17)
- Quinacrine blocks PrP (106–126)‐formed channels (2003) (17)
- Rapid solid-phase extraction method for automated gas chromatographic-mass spectrometric determination of nicotine in plasma. (1998) (17)
- Super Resolution Microscopy of SUMO Proteins in Neurons (2019) (17)
- bioNMR-based identification of natural anti-Aβ compounds in Peucedanum ostruthium. (2019) (17)
- Effect of oral monosodium glutamate on glutamic acid levels in the nucleus arcuatus of the hypothalamus and on serum osmolality of adult and infant mice. (1980) (17)
- Synthesis and binding properties of new long-chain 4-substituted piperazine derivatives as 5-HT₁A and 5-HT₇ receptor ligands. (2015) (17)
- New N- and O-arylpiperazinylalkyl pyrimidines and 2-methylquinazolines derivatives as 5-HT7 and 5-HT1A receptor ligands: Synthesis, structure-activity relationships, and molecular modeling studies. (2017) (16)
- Cellular aspartyl proteases promote the unconventional secretion of biologically active HIV-1 matrix protein p17 (2016) (16)
- EFFICACY OF CHOLESTEROL NOSE-TO-BRAIN DELIVERY FOR BRAIN TARGETING IN HUNTINGTON'S DISEASE. (2019) (16)
- Further studies on adriamycin induced in vitro lipid peroxidation. (1982) (16)
- Applicability of [11C]PIB micro-PET imaging for in vivo follow-up of anti-amyloid treatment effects in APP23 mouse model (2017) (16)
- Design and synthesis of new homo and hetero bis-piperazinyl-1-propanone derivatives as 5-HT7R selective ligands over 5-HT1AR. (2016) (16)
- Plasma and brain kinetics of large neutral amino acids and of striatum monoamines in rats given aspartame. (1990) (16)
- Monosodium glutamate kinetic studies in human volunteers. (1980) (16)
- PaCS Is a Novel Cytoplasmic Structure Containing Functional Proteasome and Inducible by Cytokines/Trophic Factors (2013) (16)
- Multigram Synthesis and in Vivo Efficacy Studies of a Novel Multitarget Anti-Alzheimer’s Compound (2015) (16)
- Structural Modifications of cis-Glycofused Benzopyran Compounds and Their Influence on the Binding to Amyloid-β Peptide. (2016) (15)
- Polyunsaturated Fatty Acids Protect Against Prion-Mediated Synapse Damage In Vitro (2010) (15)
- Monitoring the Fate of Orally Administered PLGA Nanoformulation for Local Delivery of Therapeutic Drugs (2019) (15)
- Pathogenic Aβ A2V versus protective Aβ A2T mutation: Early stage aggregation and membrane interaction. (2017) (15)
- Uptake of 14C-5-hydroxytryptamine by human and rat platelets and its pharmacological inhibition (1976) (15)
- Novel approaches for studying amyloidogenic peptides/proteins. (2013) (15)
- Simple and sensitive method for the determination of cyclophosphamide by means of a nitrogen--phosphorus-selective detector. (1978) (15)
- Relationship between changes in alveolar surfactant levels and lung defence mechanisms. (1989) (15)
- Fate of PLA and PCL-Based Polymeric Nanocarriers in Cellular and Animal Models of Triple-Negative Breast Cancer. (2016) (14)
- Can Antiviral Activity of Licorice Help Fight COVID-19 Infection? (2021) (14)
- An integrated approach for the systematic evaluation of polymeric nanoparticles in healthy and diseased organisms (2014) (14)
- Interactions of the prion peptide (PrP 106–126) with brain capillary endothelial cells: coordinated cell killing and remodeling of intercellular junctions (2011) (14)
- A new fluorogenic peptide determines proteasome activity in single cells. (2010) (14)
- The cell-permeable Aβ1-6A2VTAT(D) peptide reverts synaptopathy induced by Aβ1-42wt (2016) (14)
- Identification of a short sequence highly divergent between beta-adrenergic-receptor kinases 1 and 2 that determines the affinity of binding to betagamma subunits of heterotrimeric guanine-nucleotide-binding regulatory proteins. (1997) (14)
- Gas Chromatographic - Mass Spectrometric Studies on Styrene Toxicity (1980) (14)
- Apolipoprotein serum amyloid A down-regulates smooth-muscle cell lipid biosynthesis (1999) (14)
- Proteomic profiling of cervical and lumbar spinal cord reveals potential protective mechanisms in the wobbler mouse, a model of motor neuron degeneration. (2009) (14)
- Effect of hypothyroidism induced in adult rats on brain membrane fluidity and lipid content and composition. (1991) (14)
- Brain lipids and diet. (1997) (14)
- Review: PrP 106‐126 – 25 years after (2019) (14)
- In vivo exposure to NO2 reduces TNF and IL-6 production by endotoxin-stimulated alveolar macrophages. (1996) (13)
- A New Surface Plasmon Resonance-Based Immunoassay for Rapid, Reproducible and Sensitive Quantification of Pentraxin-3 in Human Plasma (2014) (13)
- Endotoxin regulates the maturation of sterol regulatory element binding protein-1 through the induction of cytokines. (2002) (13)
- The imbalance of brain large-chain aminoacid availability in amyotrophic lateral sclerosis patients treated with high doses of branched-chain aminoacids (1995) (13)
- Gas chromatographic-mass spectrometric determination of intact C3-hydroxylated benzodiazepine glucuronides in urine (1975) (13)
- Evaluation of epichlorohydrin (ECH) genotoxicity. Microsomal epoxide hydrolase-dependent deactivation of ECH mutagenicity in Schizosaccharomyces pombe in vitro. (1983) (13)
- The new β amyloid-derived peptide Aβ1–6A2V-TAT(D) prevents Aβ oligomer formation and protects transgenic C. elegans from Aβ toxicity (2016) (13)
- Pulmonary administration of functionalized nanoparticles significantly reduces beta-amyloid in the brain of an Alzheimer’s disease murine model (2016) (13)
- Measurement of intracellular calcium levels by the fluorescent Ca(2+) indicator Calcium-Green. (2000) (13)
- Galpha13 mediates activation of the cytosolic phospholipase A2alpha through fine regulation of ERK phosphorylation. (2006) (12)
- Alteration of SREBP activation in liver of trisomy 21 fetuses. (1999) (12)
- Cis-Glyco-Fused Benzopyran Derivatives as Hit Compounds for the Development of Therapeutic and Diagnostic Tools against Neurodegenerative Diseases (2014) (12)
- The Anti-Prion Antibody 15B3 Detects Toxic Amyloid-β Oligomers (2016) (12)
- beta 25-35 alters calcium homeostasis and induces neurotoxicity in cerebellar granule cells. (1996) (11)
- Dreaming of a New World Where Alzheimer’s Is a Treatable Disorder (2019) (11)
- Prion Diseases: Time for a Therapy ? (2003) (11)
- Fate of 1-O-octadecyl-2-O-methyl-rac-glycero-3-phosphocholine (ET18-OME) in malignant cells, normal cells, and isolated and perfused rat liver. (1995) (11)
- Defective Production of Reactive Oxygen Intermediates by Tumor‐Associated Macrophages Exposed to Phorbol Ester (1987) (11)
- Nuclear metabolism. I. Determination of styrene monooxygenase activity in rat liver nuclei. (1980) (11)
- Plasma kinetics and urinary elimination of saccharin in man. (1981) (11)
- Kinetics of 3-tert-butyl-4-hydroxyanisole (BHA) in man. (1984) (11)
- Rapid internalization of benzodiazepine receptors in the rat cortex induced by handling. (1988) (11)
- Inhibition of HMG-CoA reductase activity by hypercholesterolaemia reduces leukocyte recruitment and MCP-1 production. (2000) (11)
- Nuclear metabolism. II. Further studies on epoxide hydrolase activity. (1981) (11)
- The role of platelet activating factor in prion and amyloid-b neurotoxicity (2004) (11)
- Effect of daunomycin, adriamycin and its congener AD 32 on the activity of DNase I from bovine pancreas. (1977) (11)
- In vitro binding and metabolism of iopronic acid by rat liver microsomes. (1977) (11)
- P-19-33 Beta-25–35 induces neurotoxicity by altering calcium homeostasis in cerebellar granule cells (1996) (10)
- Oleamide‐mediated sleep induction does not depend on perturbation of membrane homeoviscosity (1999) (10)
- Biochemical effects of acute and subacute nitrogen dioxide exposure in rat lung and bronchoalveolar lavage fluid (1994) (10)
- The A2V mutation as a new tool for hindering Aβ aggregation: A neutron and x-ray diffraction study (2017) (10)
- Activity of liver microsomal mono-oxygenases on some epoxide-forming tricyclic drugs. I. Kinetics in vitro (1976) (10)
- A simple headspace gas chromatography/mass spectrometry method for the quantitative determination of the release of the antioxidants butylated hydroxyanisole and butylated hydroxytoluene from chewing gum. (2017) (10)
- In vitro effects of saccharin on cell-mediated host defence mechanisms. (1980) (10)
- Biochemical characterization of the hepatic effects in mice and rats of 1,4-bis[2-(3,5-dichloropyridyloxy)]benzene, a hepatic neoplasm promoter. (1986) (10)
- Effect of subchronic in vivo exposure to nitrogen dioxide on lung tissue inflammation, airway microvascular leakage, and in vitro bronchial muscle responsiveness in rats. (1996) (10)
- The imbalance of brain large-chain aminoacid availability in amyotrophic lateral sclerosis patients treated with high doses of branched-chain aminoacids. (1995) (10)
- Plasma pyroglutamic acid levels after oral administration of monosodium glutamate to human volunteers. (1983) (10)
- The absorption by human volunteers of glutamic acid from monosodium glutamate and from a partial enzymic hydrolysate of casein. (1978) (10)
- V363I and V363A mutated tau affect aggregation and neuronal dysfunction differently in C. elegans (2018) (9)
- Is nuclear styrene monooxygenase activity a microsomal artifact? (1980) (9)
- Styrene oxidation to styrene oxide in human erythrocytes is catalyzed by oxyhemoglobin (1983) (9)
- Ambroxol and pulmonary toxicity induced by antineoplastic drugs. (1986) (9)
- Mutagenicity, anticancer activity and blood brain barrier: similarity and dissimilarity of molecular alerts (2018) (9)
- Quantitative gas-liquid chromatographic determination of ftorafur and 5-fluorouracil in biological specimens. (1979) (9)
- Cytoplasmic domain of zebrafish myelin protein zero: adhesive role depends on beta-conformation. (2007) (9)
- N-acetyl-beta-D-glucosaminidase (NAG) levels in amniotic fluid or urine in prenatal and postnatal life. (1986) (9)
- Nanoparticles against Alzheimer's disease: PEG-PACA nanoparticles are able to link the aβ-peptide and influence its aggregation kinetic. (2010) (9)
- Fluorescent amyloid β-peptide ligand derivatives as potential diagnostic tools for Alzheimer’s disease (2013) (9)
- Role of alveolar phospholipids in bleomycin-induced pulmonary fibrosis in the rat. (1987) (8)
- Comparison of APP23, Tg2576, and APP swe -PS1 dE9 Mouse Models of Alzheimer Disease (2013) (8)
- Platelet derived growth factor induces ornithine decarboxylase activity in NIH 3T3 cells. (1985) (8)
- Pyroglutamate kinetics and neurotoxicity studies in mice. (1983) (8)
- Effect of acetylcholinesterase inhibitors on AChE-Induced PrP106–126 aggregation (2007) (8)
- Different susceptibility of mouse tissues to porphyrogenic effect of 2,3,7,8-tetrachlorodibenzo-p-dioxin. (1984) (8)
- NMR-based Lavado cocoa chemical characterization and comparison with fermented cocoa varieties: Insights on cocoa's anti-amyloidogenic activity. (2020) (8)
- Ambroxol Reduces Paraquat Toxicity in the Rat1 (1990) (7)
- Identification and Quantitative Determination of 2,3,7,8-Tetrachlorodibenzo-para-Dioxin in Animals From a Contaminated Area (1978) (7)
- Perinatal development of cytochrome P-450, NADPH-cytochrome c reductase and ethoxycoumarin deethylase in rat liver nuclear membranes. (1982) (7)
- Membrane cholesterol content and sensitivity of human carcinoma-cells to antineoplastic ether phospholipids. (1992) (7)
- Effects of aspartame and carbohydrate administration on human and rat plasma large neutral amino acid levels and rat brain amino acid and monoamine levels. (1989) (7)
- Increased transcription of transglutaminase 1 mediates neuronal death in in vitro models of neuronal stress and Aβ1–42-mediated toxicity (2020) (7)
- p17 from HIV induces brain endothelial cell angiogenesis through EGFR-1-mediated cell signalling activation (2018) (7)
- Spontaneous β‐helical fold in prion protein: The case of PrP(82‐146) (2009) (7)
- Investigating heart-specific toxicity of amyloidogenic immunoglobulin light chains: A lesson from C. elegans (2014) (7)
- Perinatal development of styrene monooxygenase and epoxide hydrolase in rat liver microsomes and nuclei. (1983) (7)
- THE PRION PROTEIN AND CELLULAR CHOLESTEROL HOMEOSTASIS (2002) (7)
- Quantitative thin-layer chromatographic measurement of n-trifluoroacetyladriamycin-14-valerate (AD 32) and trifluoroacetyladriamycin (AD 41) in blood and tissues. (1979) (7)
- Use of quasi-SMILES to model biological activity of “micelle–polymer” samples (2018) (7)
- Neuronal Localization of SENP Proteins with Super Resolution Microscopy (2020) (6)
- A Nanoscale Shape-Discovery Framework Supporting Systematic Investigations of Shape-Dependent Biological Effects and Immunomodulation (2021) (6)
- Uptake of glutamate in beagle dogs after oral gavage with MSG (1978) (6)
- Aβ Beyond the AD Pathology: Exploring the Structural Response of Membranes Exposed to Nascent Aβ Peptide (2020) (6)
- Interaction of the Anticonvulsants, Denzimol and Nafimidone, with Liver Cytochrome P450 in the Rat (1988) (6)
- Determination of dipeptides in protein hydrolysates for total parenteral nutrition. (1982) (6)
- Translational Research in Alzheimer’s and Prion Diseases (2017) (6)
- A betaPP peptide carboxyl-terminal to Abeta is neurotoxic. (1999) (6)
- Disaturated phosphatidylcholine in rabbit eustachian tube surfactant. (1990) (6)
- Single particle extinction and scattering optical method unveils in real time the influence of the blood components on polymeric nanoparticles. (2017) (6)
- A rapid electrochemical assay of lecithin in amniotic fluid using a fluoride ion-sensitive electrode. (1988) (5)
- Phospholipid composition, phosphoinositide metabolism and metastatic capacity in murine melanoma B16 variants at different stages of growth (1992) (5)
- The effect of culture medium composition on ether lipid cytotoxic activity (1993) (5)
- Induction of mixed-function oxidase by chronic treatment with 2,3,7,8-tetrachloro-dibenzo-p-dioxin in female rats. (1981) (5)
- Differential effects of benzodiazepines on phospholipid methylation in hippocampus and cerebellum of rats. (1988) (5)
- Manganese peroxidase from Phanerochaete chrysosporium. A homology-based molecular model. (1995) (5)
- Serum glutamate in rhesus macaques after gavage with MSG (1978) (5)
- Effects of chronic treatment with di-(2-ethylhexyl) phthalate on rat liver microsomal activities. (1980) (5)
- URINARY EXCRETION OF N‐ACETYL‐β‐D‐GLUCOSAMINIDASE (NAG) BY CHILDREN WITH UPPER OR LOWER URINARY TRACT INFECTIONS (1982) (5)
- Toxicological impact of titanium dioxide nanoparticles and food-grade titanium dioxide (E171) on human and environmental health (2022) (5)
- Measurement of fetal surfactant production by fluorescence polarization of amniotic fluid in complicated pregnancies. (1987) (5)
- Plasma glutamic acid levels in premature newborn. (1980) (4)
- Degradation of 2,3,7,8-tetrachlorodibenzo-p-dioxin in organic solvents by gamma ray irradiation (1978) (4)
- Regulation of macrophage functions by interferon. (1982) (4)
- Perinatal development of cytochrome P-450, cytochrome C reductase, aryl hydrocarbon hydroxylase, styrene monooxygenase, and styrene epoxide hydrolase in rabbit liver microsomes and nuclei. (1985) (4)
- Solid-state stability studies of cholecystokinin (CCK-4) peptide under nonisothermal conditions using thermal analysis, chromatography and mass spectrometry. (2010) (4)
- Comment on: Neurotoxicity of prion peptide 106–126 not confirmed, by Beat Kunz, Erika Sandmeier, Philipp Christen (2000) (4)
- In Situ Tissue Labeling of Cerebral Amyloid Using HIV-Related Tat Peptide (2018) (4)
- Effect of tyrosine on the potentiation by aspartame and phenylalanine of metrazol-induced convulsions in rats. (1991) (4)
- Structure reactivity relationships in the microsomal oxidation of tertiary amines (1984) (4)
- N-Terminally Truncated and Pyroglutamate-Modified Aβ Forms Are Measurable in Human Cerebrospinal Fluid and Are Potential Markers of Disease Progression in Alzheimer’s Disease (2021) (4)
- Characterization of antimalarial SPf66 peptide using MALDI–TOF MS, CD and SEC (2002) (4)
- Kinetics of monosodium glutamate in human volunteers under different experimental conditions. (1985) (4)
- Evolution toward beta common chain receptor usage links the matrix proteins of HIV-1 and its ancestors to human erythropoietin (2020) (4)
- Internalization of nanopolymeric tracers does not alter characteristics of placental cells (2016) (4)
- Peroxidase, mixed-function oxidase and metal- catalyzed oxidation of phenylpropenoidic compounds (1988) (4)
- Antitumour drugs targeting tau R3 VQIVYK and Cys322 prevent seeding of endogenous tau aggregates by exogenous seeds (2021) (4)
- Effect of iodinated contrast media on the synthesis and metabolism of leukotriene B4. (1991) (3)
- Cytotoxicity of PrP Peptides (2004) (3)
- Fetal lung maturity evaluation with fluorescence polarization of the amniotic fluid (1993) (3)
- Doxycycline Inhibition of a Pseudotyped Virus Transduction Does Not Translate to Inhibition of SARS-CoV-2 Infectivity (2021) (3)
- Non-linear kinetics of microsomal styrene monooxygenase after phenobarbital pre-treatment (1980) (3)
- Nonphosphorylated tau slows down Aβ1–42 aggregation, binds to Aβ1–42 oligomers, and reduces Aβ1–42 toxicity (2021) (3)
- A novel bio-inspired strategy to prevent amyloidogenesis and synaptic damage in Alzheimer’s disease (2022) (3)
- Determination of fetal lung maturity in rats by fluorescence polarization. (1986) (3)
- Prostaglandin endoperoxide synthetase and the activation of benzo(a)pyrene to reactive metabolites in vivo in guinea pigs. (1984) (3)
- NMR-Driven Identification of Cinnamon Bud and Bark Components With Anti-Aβ Activity (2022) (3)
- Effect of iodinated contrast media on the synthesis and metabolism of leukotriene B4. (1990) (3)
- Protein kinase C is not involved in cholesterol-induced resistance to synthetic ether lipids. (1993) (3)
- Kinetic behaviour of microsomal styrene monooxygenase and styrene epoxide hydratase in different animal species (1977) (3)
- Protection against acute paraquat toxicity by ambroxol (1991) (3)
- The oral administration of msg at varying concentrations to male mice (1978) (3)
- The mode of dexamethasone decoration influences Avidin-nucleic-acid-Nano-assembly organ biodistribution and in vivo drug persistence. (2021) (3)
- Quantitative analysis of proteins which are members of the same protein complex but cause locus heterogeneity in disease (2020) (3)
- A PRION PROTEIN FRAGMENT MODIFIES PLASMA MEMBRANE VISCOSITY AND INTRACELLULAR. CALCIUM LEVEL: 151 (1995) (3)
- of Golgi membranes by acylating lysophosphatidic acid (1999) (3)
- Possible relevance of N-trifluoroacetyladriamycin (AD 41) in the antitumoral activity of N-trifluoroacetyladriamycin-14-valerate (AD 32) in tumor-bearing mice. I. Pharmacokinetic evidence. (1980) (3)
- Solubilization and characterization of d-fenfluramine binding sites from bovine cerebral cortex. (1994) (3)
- Micro- and Nanoplastics’ Effects on Protein Folding and Amyloidosis (2022) (3)
- Intraluminal inflammation in the airways of patients with chronic bronchitis after treatment with Ambroxol. (1995) (3)
- Synthetic ether lipids fluidizing action and cell membrane lipid composition: A commentary note (1992) (3)
- Cellulose nanocrystals: a multimodal tool to enhance the targeted drug delivery against bone disorders. (2020) (2)
- Mutagenic relevance of rat hepatocyte nuclei in the activation and inactivation of xenobiotica. Cyclophosphamide and epichlorohydrin activity on the yeasts S. pombe and S. cerevisiae. (1983) (2)
- Alzheimer’s Disease Prevention through Natural Compounds: Cell-Free, In Vitro, and In Vivo Dissection of Hop (Humulus lupulus L.) Multitarget Activity (2022) (2)
- The soothing effect of menthol, eucalyptol and high-intensity cooling agents (2019) (2)
- Sleep inhibition induced by amyloid‐β oligomers is mediated by the cellular prion protein (2020) (2)
- CORRELATION BETWEEN NEWBORN GASTRIC ASPIRATE MICROVISCOSITY AND GESTATIONAL AGE (1985) (2)
- ST1859 reduces prion infectivity and increase survival in experimental scrapie (2009) (2)
- Regulation of the Tumoricidal and Suppressive Activity of Human Macrophages (1983) (2)
- GLC-mass fragmentographic determination of saccharin in biological fluids. (1981) (2)
- Clinical assessment of fetal lung maturity in high risk pregnancies using fluorescence polarization. (1988) (2)
- Alpha 1-antitrypsin variants produced by recombinant DNA: differences in elastase inhibitory activity and resistance to oxidant agents. (1990) (2)
- Nuclear drug metabolism: its ontogeny in the rat and its presence in human fetal life. (1983) (2)
- The effect of chewing gum on gastric fluid volume and pH in healthy subjects (2012) (2)
- Super-Resolution Imaging to Study Co-Localization of Proteins and Synaptic Markers in Primary Neurons. (2020) (2)
- Induction of Epithelial-Mesenchymal Transition (EMT) by Neutrophil Extracellular Traps (NETs) as Possible Molecular Mechanism in CLAD (2021) (2)
- Food-Grade Titanium Dioxide Induces Toxicity in the Nematode Caenorhabditis elegans and Acute Hepatic and Pulmonary Responses in Mice (2022) (2)
- In vivo anti‐tumor activity of synthetic ether lipids is not enhanced by pharmacological modulation of tumor lipid composition (1994) (2)
- Induction of nuclear styrene monooxygenase and epoxide hydrolase in rat liver (1981) (1)
- Cognitive improvement and anti-amyloidogenic effect of doxycycline in a double transgenic mouse model of Alzheimer disease (2011) (1)
- Sinthetic peptides homologous to prion protein fragments form amyloid-like fibrils in vitro (1992) (1)
- Esterase activity of rat muscle (2010) (1)
- Reactive Oxygen Intermediates in Tumor Necrosis Factor Production and Endotoxic Shock (1993) (1)
- Synthesis and Preliminary Biological Evaluation of Fluorescent Glycofused Tricyclic Derivatives of Amyloid β-Peptide Ligands (2016) (1)
- Therapeutic Approaches to Prion Diseases : In Vitro Studies with Tetracycline Compounds (2002) (1)
- Abstracts of the 15th Annual Meeting of the Israel Society for Neuroscience Eilat, Israel, December 3–5, 2006 (2006) (1)
- Synthesis and Molecular Modelling Studies of New 1,3-Diaryl-5-Oxo-Proline Derivatives as Endothelin Receptor Ligands (2020) (1)
- Protein Aggregates in Neurodegenerative Disorders (2008) (1)
- Apelin Resistance Contributes to Muscle Loss during Cancer Cachexia in Mice (2022) (1)
- Abeta peptide-small molecule interaction studies as a tool for the development of new anti-Alzheimer's drugs (2010) (1)
- Ftorafur: A self-limiting source of 5-fluorouracil? (2004) (1)
- Effect of paf antagonists on the cytotoxic activity of antineoplastic ether phospholipids. (1993) (1)
- In vivo studies of rat alveolar macrophase microviscosity: Influence of pulmonary surfactant synthesis stimulation (2007) (1)
- [1]Benzothieno[3,2-d]pyrimidine derivatives as ligands for the serotonergic 5-HT7 receptor. (2019) (1)
- Anti-amyloidogenic effect of tetracyclines in Prion and Alzheimer disease models (2002) (1)
- N-acetyl-beta-D-glucosaminidase (NAG) and NAG isoenzymes in children with upper and lower urinary tract infections. (1983) (1)
- In vivo studies of rat alveolar macrophage [corrected] microviscosity: influence of pulmonary surfactant synthesis stimulation. (1987) (1)
- In vivo studies of rat alveolar macrophage microviscosity: Influence of pulmonary surfactant synthesis stimulation (2007) (1)
- The purification of histones by metal-chelate chromatography. (1994) (1)
- Relationship of in vitro hydrolysis of 17-chloroacetylajmaline and 17-acetylajmaline in different animal species. (1975) (1)
- Preparation and characterization of lipid-based nanoparticles binding with high affinity amyloid-β1-42 peptide (2010) (1)
- An automated system for animal exposure to nitrogen dioxide. (1994) (1)
- Analytical validity of electrochemical determination of lecithin for establishing foetal lung maturity in normal and complicated pregnancies. (1993) (1)
- Membrane proteins and Aβ peptide toxicity (2009) (1)
- Anti-amyloidogenic activity of tetracyclines: In vitro studies (2000) (1)
- cis-Glycofused Benzopyran Compounds as New Amyloid-β Peptide Ligands. (2012) (1)
- "Production, purification and aggregation of IgE lambda light chain fragment" (2010) (1)
- The similarity of inherited diseases (II): clinical and biological similarity between the phenotypic series (2020) (1)
- Lung Defensive System: Damages and Treatment (2004) (0)
- Microsoft Word-Miniprion-JBCr (2002) (0)
- Dysmyelination and glycolipid interference caused by phenylalanine in phenylketonuria. (2022) (0)
- , Products In Vivo Anti-Inflammatory Effect of Statins Is Mediated by Nonsterol Mevalonate (2001) (0)
- Effect of Non-Nutritive Sweeteners on the Gut Microbiota (2023) (0)
- 290 – STUDIES ON THE ACTIVITY OF LIVER MICROSOMAL EPOXIDE SYNTHETASE AND HYDRASE ON EPOXIDE FORMING TRICYCLIC DRUGS (1977) (0)
- European advanced translational research infrastructure in medicine (EATRIS) (2011) (0)
- Synthetic Abeta 1-40 oligomers impair recognition memory in mice (2009) (0)
- EFFECT OF SIMULTANEOUS ADMINISTRATION OF TCOD AND TCDF AND OF MIXTURES FROM INCINERATOR ON ANTIBODY PRODUCTION (2003) (0)
- A soluble form of prion protein in human cerebrospinal fluid as a potential source of PRP amyloid (1992) (0)
- Quantitative analysis of proteins which are members of the same protein complex but cause locus heterogeneity in disease (2020) (0)
- TOXICOLOGICAL STUDIES ON SINGLE-CELL PROTEIN (1979) (0)
- Abeta 1-40 and 1-42 oligomer-mediated memory impairment does not require cellular prion protein (2010) (0)
- ePS4.01 Open randomised study on docosahexaenoic acid, 5-methyltetrahydrofolate and vitamin B12 supplementation in cystic fibrosis paediatric patients: focus on fatty acids, inflammation and blood cell membranes (2019) (0)
- 415 Role of calcium in β 25–35-induced neurotoxicity in cerebellar granule cells (1996) (0)
- I07 A new generation of brain-targeted nanoparticles for cholesterol delivery in huntington’s disease: kinetics, drug release and behavioral effects in mouse models (2021) (0)
- MODULATION OF MACROPHAGE CYTOLYSIS BY INTERFERON (1982) (0)
- Opposite role of SIRT1 and SIRT2 in neurodegeneration (2009) (0)
- 137 – GEL-ENTRAPPED MICROSOMES: A NEW TOOL FOR THE STUDY OF DRUG METABOLISM (1977) (0)
- Regulatory activity of interferon on macrophage cytolytic and suppressive capacity (1982) (0)
- An early developmental vertebrate model to assess nanomaterial safety: Bridging cell- based and mammalian nanoparticle toxicity assessment (2017) (0)
- HIV-1 matrix protein p17 misfolding forms toxic amyloidogenic assemblies that induce neurocognitive disorders (2017) (0)
- Short Communication f3PP and Tau Interaction A Possible Link between Amyloid and Neurofibrillary Tangles in Alzheimer's Disease (2007) (0)
- D14 Plasma levels of 24S-hydroxycholesterol are reduced in Huntington disease subjects: preliminary results of a 2-year longitudinal study (2022) (0)
- Front Cover: Flavonoid‐Derived Human Phenyl‐γ‐Valerolactone Metabolites Selectively Detoxify Amyloid‐β Oligomers and Prevent Memory Impairment in a Mouse Model of Alzheimer's Disease (2020) (0)
- Early Changes in the Urinary Excretion of Porphyrins by Female Rats in the Course of Chronic TCDD Treatment (1981) (0)
- Prion protein fragment 106–126-induces astroglial proliferation through the activation of l-type calcium channels (1995) (0)
- [Pharmacologic stimulation of surfactant at the pulmonary level]. (1987) (0)
- Prion and Prion-like Diseases in Humans (2013) (0)
- Biochemical and biophysical features of disease-associated tau mutants V363A and V363I (2022) (0)
- Nano-liposomes targeting Abeta peptide and functionalized to interact with the blood-brain barrier (2011) (0)
- From the lungs to the brain: The fantastic voyage of nanoparticles targeting beta-amyloid (Aβ) (2016) (0)
- Cytokine production by glioblastoma and astrocytoma cell lines after stimulation with the human prion peptide 82–146 (1998) (0)
- 2091 – NUCLEAR MONOOXYGENASES: KINETICS OF IN VITRO FORMATION OF STYRENE-7, 8-OXIDE USING STYRENE AS SUBSTRATE (1978) (0)
- Nanoparticle-based strategy to cross the BBB: the potential for the therapy of Alzheimer’s disease (2015) (0)
- P4-415 ST1859 reduces prion infectivity and increase survival in experimental scrapie (2004) (0)
- In Situ Tissue Labeling of Cerebral Amyloid Using HIV-Related Tat Peptide (2018) (0)
- Potential nanotherapeutic approach for Alzheimer's disease: in vitro clearance of beta-amyloid across the blood-brain barrier by multifunctional liposomes (2015) (0)
- A neurotoxic prion protein fragment induces hypertrophy and proliferation of rat astroglial cells in vitro. (1994) (0)
- Potentials of liposomes in diagnosis and treatment of pulmonary metastases: an experimental study in the rat. (1996) (0)
- 161 PrP peptides and pathogenesis of prion diseases (1996) (0)
- Spontaneous spongiform encephalopathy in a young adult rhesus monkey. (1996) (0)
- Contents, Vol. 51, Supplement 1, 1987 (1987) (0)
- Basic proteins and basic membranes adjusting blotting and staining conditions to immobilon CD (1995) (0)
- Tat-1-liposomes to overcome the blood-brain barrier: an in vitro study (2010) (0)
- PROSTAGLANDlNS AND AMINOGLYCOSIDE NEPHROTOXICITY (1985) (0)
- Cytoskeleton Elements Contribute to Prion Peptide-Induced Endothelial Barrier Breakdown in a Blood–Brain Barrier In Vitro System (2022) (0)
- Chemerin As a New Potential Player in the Immunoregulatory Activity of Mesenchymal Stromal Cells (2014) (0)
- Cytoplasmic Domain of Zebrafish Myelin Protein Zero: Adhesive Role Depends on b -Conformation (2007) (0)
- Methods for Studying Prion Protein Amyloid (1996) (0)
- Short Communication A b PP Peptide Carboxyl-Terminal to A b Is Neurotoxic (1999) (0)
- 136 – DRUG ESTERS METABOLISM BY MUSCLE ESTERASES(°) (1977) (0)
- Chronic cholesterol administration to the brain supports complete and long-lasting cognitive and motor amelioration in Huntington’s disease (2023) (0)
- Determination of steviol glycosides in seven Stevia rebaudiana (Bertoni) extracts routinely used in the food and confectionary industry (2017) (0)
- [Fluorescence polarization for measuring the production of surfactant in pathological pregnancies]. (1987) (0)
- P183 Increase of HLA-G in plasma of cystic fibrosis paediatric patients treated with Docosahexaenoic acid (DHA) (2020) (0)
- Liposomes containing acid lipids and functionalized with a peptide eliciting an efficient removal of beta-amyloid peptide burden from the brain of animal models (transgenic mice) of Alzheimer disease. (2012) (0)
- PrP Peptides as a Tool to Investigate the Pathogenesis of Prion Protein Amyloidoses (1998) (0)
- CLUSTERIN REDUCES THE FORMATION OF BIOLOGICAL RELEVANT TOXIC SOLUBLE ABETA1-42 OLIGOMERS (2014) (0)
- A new APP mutation prevents synaptic degeneration in Alzheimer Disease model (2014) (0)
- Neurodegenerative effects induced by β-amyloid and PRP peptides: Similarities and differences (1994) (0)
- L15 LOCAL STRIATAL EXPRESSION OF THE CHOLESTEROL DEGRADATION ENZYME, CYP46A1, IN ZQ175 MICE: BEHAVIOURAL AND NEUROPATHOLOGICAL EVALUATION (2016) (0)
- Inhibition of liver microsomal epoxide hydrase by cyproheptadine epoxide (1977) (0)
- Fluorescence polarization changes with gestational age in amniotic fluid of rabbit and guinea pig. (1990) (0)
- Effect of ambroxol on rabbit eustachian tube surfactant. (1992) (0)
- Cell membrane viscosity is increased by a prion protein fragment (1994) (0)
- Author Index / Subject Index, Vol. 51, Supplement 1, 1987 (1987) (0)
- Production of cytokines and eicosanoids in a synovial model of inflammation (1995) (0)
- The A2V mutation as a new tool for hindering Aβ aggregation: A neutron and x-ray diffraction study (2017) (0)
- Nanoparticles for therapy of Alzheimer Disease (2013) (0)
- Protein Nitration in Amyotrophic Lateral Sclerosis; Possible Multifunctional Role in the Pathogenesis Mass Spectrometry-based Strategies for Identification of Reversibly Oxidized Endogenous Protein-tyrosine Phosphatases in Cancer Cells (2005) (0)
- 887 – ARENE OXIDES IN THE METABOLISM OF TRICYCLIC DRUGS: COVALENT BINDING, TOXICITY (1978) (0)
- Brain Dysfunction Associated with Amyloid Fibrils and Other Aggregated Proteins (2008) (0)
- The similarity of inherited diseases (I): clinical similarity within the phenotypic series (2021) (0)
- A prion protein fragment increases intracellular calcium and activates superoxide production and cell migration of human neutrophils through a receptor-mediated mechanism (1995) (0)
- ANTHRACYCLINES EFFECTIVE AGAINST EXPERIMENTAL SCRAPIE (1997) (0)
- P4-277: Beta-amyloid interferes with cognitive functions in an aggregation status-dependent manner (2008) (0)
- Poster communicationEffect of L-carnitine and L-acetyl-carnitine on an animal model of reye syndrome (1992) (0)
- S1-03-06: Treatment of transmissible spongiform encephalopathies with doxycycline (2006) (0)
- [Incorporation of labeled phospholipids in Eustachian tube surfactant]. (1987) (0)
- Subject Index, Vol. 55, Supplement 1, 1989 (1989) (0)
- Good Protein, Bad Protein: A New Aβ Variant Can Be Both (2009) (0)
- A portable optical-fibre-based surface plasmon resonance biosensor for the detection of therapeutic antibodies in human serum (2020) (0)
- A new immunoassay based on surface plasmon resonance for detection of β-amyloid oligomers (2011) (0)
- Haem oxygenase-1 mRNA induction by a prion protein fragment in rat astroglial cells (1995) (0)
- Contents, Vol. 55, Supplement 1, 1989 (1989) (0)
- The similarity of inherited diseases (I): clinical similarity within the phenotypic series (2021) (0)
- L16 Identifying a therapeutic regimen for cholesterol delivery to huntington’s disease brain (2016) (0)
- Effect of cell density on cytotoxicity of ether lipid analogues in variants of B16 murine melanoma (1993) (0)
- Differential metabolic fate of octadecyl-methyl-alycero-3-phosohocholine (ET18-OMe) in tumoral cells, normal cells and isolated and oerfused liver (1994) (0)
- Phenotypic heterogeneity of Alzheimer's disease: Toward the identification of molecular determinants underlying distinct clinicopathological subgroups (2012) (0)
- A nanomedicine-based therapeutic approach restores memory and ameliorates amyloid pathology in Alzheimer's mouse models (2015) (0)
- Chemerin Produced By Mesenchymal Stromal Cells (MSC) Is an Important Factor for In Vivo macrophage Migration (2015) (0)
- Contents, Vol. 59, Supplement 1, 1992 (1992) (0)
- An Integrated Approach to Investigate Toxic Oligomers of Amyloidogenic Proteins and Potential Inhibitors: Application to the Effects of Humanin on Aβ Oligomers (2017) (0)
- CYCLODEXTRINS COUNTERACT PROTEIN AGGREGATION IN A SPINOBULBAR MUSCULAR ATROPHY (2009) (0)
- IN VITRO NEUROTOXICITY OF A FRAGMENT OF THE PRION PROTEIN: IMPLICATIONS FOR PRION-RELATED ENCEPHALOPATHIES (1993) (0)
- Synthetic Abeta 1-40 oligomers impair recognition memory in mice (2009) (0)
- Mono and Dually Decorated Nanoliposomes for Brain Targeting, In Vitro and In Vivo Studies (2013) (0)
- The role of platelet activating factor in prion and amyloid-&bgr; neurotoxicity (2004) (0)
- I17 Sustained benefits of brain-permeable cholesterol-loaded nanoparticles in zQ175DN mouse model (2022) (0)
- HO-1 and GSH mediate cancer cell resistance to Bortezomib : role of Nrf 2 (2014) (0)
- New drugs, new concepts in therapy of metastatic disease; antimetastatic compounds (2004) (0)
- Activity of liver microsomal mono-oxygenases on some epoxide-forming cyclic tricyclic drugs. I. Kinetics in vitro. (1976) (0)
- Inhibition of phospholipase D activity in normal tissues by ET 18-OMe (1995) (0)
- A Surface Plasmon Resonance-based assay to measure serum concentrations of therapeutic antibodies and anti-drug antibodies (2019) (0)
- Gas chromatographic-mass spectrometric determination of intact C3-hydroxylated benzodiazepine glucoronides in urine. (1975) (0)
- Variations in Biodistribution and Acute Response of Differently Shaped Titania Nanoparticles in Healthy Rodents (2023) (0)
- Targeting ß-amyloid by the A2V Aß variant: a novel disease-modifying strategy for the treatment of Alzheimer’s disease (2014) (0)
- dissociation inhibitor alpha (GDI)/Rab11 pathway (2009) (0)
- Effect of ambroxol on surfactant of rabbit eustachian tube (1990) (0)
- The prion protein fragment 106-126 stimulates inducible nitric oxide synthase in human microglia via the activation of p38 mitogen-activated protein kinase (2001) (0)
- The similarity of inherited diseases (II): clinical and biological similarity between the phenotypic series (2020) (0)
This paper list is powered by the following services:
What Schools Are Affiliated With Mario Salmona?
Mario Salmona is affiliated with the following schools:
